Rules › DEA-2023-0028

Expansion of Induction of Buprenorphine via Telemedicine Encounter

Proposed rule from the Justice Department, Drug Enforcement Administration (docket DEA-2023-0028). 99 comment letters from companies and organizations are listed below.

Agency

Justice Department, Drug Enforcement Administration

Docket

DEA-2023-0028

Published

2023-03-01

Comments due

2023-03-31

Status

Comment period closed March 31, 2023 · no final rule found yet

Total public comments

2,884

Letters listed here

99

Joint letters

3, adding 6 more organizations as co-signers

Federal Register notice ↗ · Docket on Regulations.gov ↗

Who commented, by industry

Healthcare 64 Advocacy & Nonprofits 11 Other 10 Pharma & Medical Devices 7 Insurance 4 Technology, Media & Telecom 2 Environment & Conservation 1

Who commented